v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Conversion of Convertible Notes
Common stock
Common stock
Conversion of Convertible Notes
Additional paid in capital
Additional paid in capital
Conversion of Convertible Notes
Acc. other comprehensive (loss) income
Treasury stock
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024     251,554,378            
Beginning balance at Dec. 31, 2024 $ (3,714)   $ 26   $ 625,130   $ 121 $ (57,350) $ (571,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (288,084)               (288,084)
Foreign currency translation adjustments (315)           (315)    
Unrealized losses on available for sale investments, net 0                
Equity-based compensation expense 17,040       17,040        
Exercise of options (in shares)     1,868,022            
Exercise of options 3,604       3,604        
Issuance of shares upon conversion of 2029 Notes (in shares)       16,658,335          
Issuance of shares upon conversion of 2029 Notes   $ 135,599   $ 2   $ 135,597      
Issuance of shares purchased under ESPP (in shares)     571,875            
Issuance of shares purchased under ESPP 1,069       1,069        
Issuance of shares for equity-based compensation awards, net tax settlements (in shares)     6,987,676            
Issuance of shares for equity-based compensation awards, net of tax settlements (2,036)   $ 1   (2,037)        
Issuance of shares for paid-in-kind interest on 2029 Notes (in shares)     1,084,119            
Issuance of shares for paid-in-kind interest on 2029 Notes 4,095       4,095        
Proceeds from exercise of warrants (in shares)     14,800,000            
Proceeds from exercise of warrants 113,954   $ 2   113,952        
Issuance of shares from at-the-market offering (in shares)     142,253,313            
Issuance of shares from at-the-market offering 628,804   $ 15   628,789        
Ending balance (in shares) at Sep. 30, 2025     435,777,718            
Ending balance at Sep. 30, 2025 610,016   $ 46   1,527,239   (194) (57,350) (859,725)
Beginning balance (in shares) at Jun. 30, 2025     369,171,608            
Beginning balance at Jun. 30, 2025 266,550   $ 39   1,186,256   (149) (57,350) (862,246)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) 2,521               2,521
Foreign currency translation adjustments (45)           (45)    
Unrealized losses on available for sale investments, net 0                
Equity-based compensation expense 5,321       5,321        
Exercise of options (in shares)     742,808            
Exercise of options 1,971       1,971        
Issuance of shares for equity-based compensation awards, net tax settlements (in shares)     863,302            
Issuance of shares for equity-based compensation awards, net of tax settlements (356)       (356)        
Issuance of shares from at-the-market offering (in shares)     65,000,000            
Issuance of shares from at-the-market offering 334,054   $ 7   334,047        
Ending balance (in shares) at Sep. 30, 2025     435,777,718            
Ending balance at Sep. 30, 2025 $ 610,016   $ 46   1,527,239   (194) (57,350) (859,725)
Beginning balance (in shares) at Dec. 31, 2025 436,955,655   436,955,655            
Beginning balance at Dec. 31, 2025 $ 611,870   $ 46   1,534,792   (63) (57,350) (865,555)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (174,366)               (174,366)
Foreign currency translation adjustments 146           146    
Unrealized losses on available for sale investments, net (2,091)           (2,091)    
Equity-based compensation expense $ 12,790       12,790        
Exercise of options (in shares) 43,430   43,430            
Exercise of options $ 80       80        
Issuance of shares upon conversion of 2029 Notes (in shares)       38,069,987          
Issuance of shares upon conversion of 2029 Notes   $ 233,357   $ 3   $ 233,354      
Issuance of shares purchased under ESPP (in shares)     315,409            
Issuance of shares purchased under ESPP 1,590       1,590        
Issuance of shares for equity-based compensation awards, net tax settlements (in shares)     5,043,727            
Issuance of shares for equity-based compensation awards, net of tax settlements (1,735)       (1,735)        
Retirement of treasury stock $ 0       (57,350)     57,350  
Ending balance (in shares) at Sep. 30, 2026 480,428,208   480,428,208            
Ending balance at Sep. 30, 2026 $ 681,641   $ 49   1,723,521   (2,008) 0 (1,039,921)
Beginning balance (in shares) at Jun. 30, 2026     479,494,493            
Beginning balance at Jun. 30, 2026 770,324   $ 49   1,719,285   (943) 0 (948,067)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income (loss) (91,854)               (91,854)
Foreign currency translation adjustments 3           3    
Unrealized losses on available for sale investments, net (1,068)           (1,068)    
Equity-based compensation expense 4,624       4,624        
Issuance of shares for equity-based compensation awards, net tax settlements (in shares)     933,715            
Issuance of shares for equity-based compensation awards, net of tax settlements $ (388)       (388)        
Ending balance (in shares) at Sep. 30, 2026 480,428,208   480,428,208            
Ending balance at Sep. 30, 2026 $ 681,641   $ 49   $ 1,723,521   $ (2,008) $ 0 $ (1,039,921)